membrane bio reactor
Scope
Date
~
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
CGBio opens cosmetic surgery clinic in Bali using bio-medical tech
CGBio, a South Korean bio-renewable medical company, announced on Monday that it opened a medical esthetic clinic, called Nulook, in Bali, Indonesia...
Mar 14, 2023 (Gmt+09:00)
-
Companies
CJ CheilJedang opens internal venture development space Inno Play
South Korea's food and bio giant CJ CheilJedang Corp. on Sunday said it opened Inno Play, an office space for commercializing innovative ideas and d...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
CJ CheilJedang invests in Australian bio startup
South Korea's food and bio company CJ CheilJedang Corp. on Wednesday said it will invest in the Australian bio startup Provectus Algae.The former se...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Energy
KHNP, Westinghouse in talks to resolve Poland reactor dispute
Korea Hydro & Nuclear Power Co. (KHNP) and Westinghouse Electric Co. are in negotiations to settle their dispute over reactor design licensing, ...
Feb 24, 2023 (Gmt+09:00)
-
Korean stock market
S.Korean firms with focus on emerging Asia to shine
South Korean companies with a large proportion of sales to emerging Asia are expected to shine in the stock market this year as their revenue from t...
Feb 24, 2023 (Gmt+09:00)
-
Real estate
Korea's Cha Bio Group to expand overseas real estate business
Cha Bio Group, consisting of Cha Biotech and Cha Vaccine Research Institute as its subsidiaries, has announced its expansion into the real estate in...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
EOFlow's insulin injection pump starts to be sold in UAE
South Korea's medical device maker EOFlow Co. started selling the wearable insulin pump EOPatch in the United Arab Emirates.The company said on Tues...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials
Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...
Feb 08, 2023 (Gmt+09:00)
-
Construction
South Korea's SK Ecoplant localizes core tech to make ultrapure water
South Korea's SK Ecoplant Co. is expanding its portfolio in the water industry through localizing core technology to produce ultrapure water (UPW), ...
Feb 07, 2023 (Gmt+09:00)
-
Energy
S.Korea's science minister calls small modular reactors 'game changers'
Minister of Science and ICT Lee Jong-ho on Thursday pledged full support for the development of small modular reactors (SMRs), which he called a "ga...
Feb 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
UK's Croda to buy Korean bio materials maker for $286 mn
Croda International Plc., a British specialty chemicals company, is set to acquire South Korean bio materials producer Solus Biotech Co. for some 35...
Feb 02, 2023 (Gmt+09:00)
-
Perspectives
Korea’s nuclear power: Ample export opportunities ahead
The recent energy crisis dealt a particularly hard blow to Europe given its heavy dependency on Russian gas. The world was once again awakened to th...
Jan 30, 2023 (Gmt+09:00)
-
Venture capital
Korea's venture capital investment falls 12% last year amid downturn
South Korea's venture capital investment last year fell more than 10% from a year ago due to the economic downturn caused by a series of global rate...
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
DongKoo Bio signs MOU to move into SE Asian healthcare market
DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, th...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Hancom Carelink invests in bio big data venture 3bigs
South Korea's Hancom Carelink, a digital health care company under Hancom Group, on Wednesday said it bought an unspecified stake in the bio big dat...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong accelerates investment in CDMO business
Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Inc. eyes significant growth in bio business from 2024
SAN FRANCISCO – SK Inc., the investment and holding company of South Korea’s SK Group, expects significant growth in its biopharma...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte to invest more in US bio biz, spend $3 bn in Korea
SAN FRANCISCO -- South Korea’s Lotte Biologics Co. is considering investing more in the US bio industry and spending $3 billion in new factori...
Jan 11, 2023 (Gmt+09:00)
-
Bio & Pharma
SK bio families to present visions to global investors at SK Bio Night
SK Inc., the investment company of SK Group, said on Tuesday that it will hold a networking event called "SK Bio Night" in the US along with its bio...
Jan 10, 2023 (Gmt+09:00)
-
Energy
Seoul in talks to share nuclear plant export profits with Westinghouse
Korea Hydro & Nuclear Power Co. and its parent company Korea Electric Power Corp. are in discussion with Westinghouse Electric Corp. to share pr...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Hansol Chemical to enter bio industry with BiOCS acquisition
Hansol Chemical Co., a unit of South Korea’s paper-focused conglomerate Hansol Group, is expanding its business scope to biomaterials by acqui...
Dec 27, 2022 (Gmt+09:00)
-
Venture capital
Korea’s big bio startups to launch $39 mn investment fund
South Korea’s four leading biotech firms plan to launch an investment fund of up to 50 billion won ($39 million) to support smaller domestic b...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Bigsome Bio signs tech transfer agreement with university
Bigsome Bio, a subsidiary of Lotte Chilsung Beverage, has begun research on functional materials for respiratory health.The company said on Friday t...
Dec 20, 2022 (Gmt+09:00)
-
Carbon neutrality
SK Group to display eco-friendly tech at next month's CES
South Korea's SK Group next month will display an extended range of carbon-reducing products and technologies at CES 2023, the world's largest exhib...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's 2021 bio sector output $15.4 bn; 5-year annual growth 20%
South Korea's bio industry last year exceeded 20 trillion won ($15.4 billion) in production for the first time and continues to see strong growth.Th...
Dec 15, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand